| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | George Dimopoulos | |
| Katerina Kaziani | |||
| Elli Mitrakou | |||
| P2860 | cites work | Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Q24811601 |
| How should we approach Aspergillus in lung secretions of patients with COPD? | Q28068350 | ||
| Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome | Q28264458 | ||
| Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis | Q34385038 | ||
| Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes | Q35131913 | ||
| Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis | Q35789251 | ||
| Utility of Aspergillus antigen detection in specimens other than serum specimens | Q35951605 | ||
| Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study | Q36633947 | ||
| Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study | Q36886708 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Invasive aspergillosis in the intensive care unit | Q38066616 | ||
| Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. | Q39367515 | ||
| Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients | Q40585861 | ||
| Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients | Q41998776 | ||
| Invasive aspergillosis in the ICU: an emerging disease | Q44610230 | ||
| Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease. | Q45163172 | ||
| A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients | Q46059175 | ||
| Diagnosis of invasive fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). | Q52949459 | ||
| Aspergillosis | Q55951920 | ||
| Galactomannan in Bronchoalveolar Lavage Fluid | Q57559940 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance | Q80312940 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intensive care unit | Q5094647 |
| invasive pulmonary aspergillosis | Q54946623 | ||
| P304 | page(s) | 352 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Annals of Translational Medicine | Q26842362 |
| P1476 | title | Improving diagnostic accuracy for invasive pulmonary aspergillosis in the intensive care unit | |
| P478 | volume | 4 |
Search more.